Belpointe Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-106
| Closed | -$7.8K | – | 2132 |
|
|
2023
Q1 | $7.8K | Buy |
106
+6
| +6% | +$441 | ﹤0.01% | 2841 |
|
|
2022
Q4 | $6.68K | Buy |
+100
| New | +$6.68K | ﹤0.01% | 2813 |
|
|
2020
Q1 | – | Sell |
-2,124
| Closed | -$138K | – | 715 |
|
|
2019
Q4 | $138K | Sell |
2,124
-160
| -7% | -$10.4K | 0.02% | 663 |
|
|
2019
Q3 | $142K | Buy |
+2,284
| New | +$142K | 0.02% | 570 |
|